Funder: National Institutes of Health
Due Dates (Anticipated): September 2026 (Full application deadline, projected)
Funding Amounts: Award ceiling not specified; 100% matching funds required; typical duration/project size varies by project scope.
Summary: Provides additional funding to U.S. small businesses with prior NIH SBIR/STTR Phase II awards to bridge the commercialization gap for high-impact biomedical technologies.
Key Information: Only one Phase IIB Strategic Breakthrough award per project; applications must demonstrate at least 100% matching funds.